GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Themis Medicare Ltd (BOM:530199) » Definitions » 3-Year EBITDA Growth Rate

Themis Medicare (BOM:530199) 3-Year EBITDA Growth Rate : 6.30% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Themis Medicare 3-Year EBITDA Growth Rate?

Themis Medicare's EBITDA per Share for the three months ended in Dec. 2024 was ₹0.81.

During the past 12 months, Themis Medicare's average EBITDA Per Share Growth Rate was 4.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 54.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Themis Medicare was 167.30% per year. The lowest was -48.50% per year. And the median was 8.60% per year.


Competitive Comparison of Themis Medicare's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Themis Medicare's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Themis Medicare's 3-Year EBITDA Growth Rate falls into.


;
;

Themis Medicare 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Themis Medicare  (BOM:530199) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Themis Medicare 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Themis Medicare's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Themis Medicare Business Description

Traded in Other Exchanges
Address
Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.

Themis Medicare Headlines

No Headlines